Biotech Values

[ghmm]

ITEK:

They pushed the date back slightly I think first couple weeks in January. Their other program is a combination Phase 2. Sorry don't know if they've guided to data release. They had said (close to a year ago maybe) that they would have some early proof of concept work from other back-of-the-eye diseases but they haven't mentioned it. I don't follow them quite as closely now as I sold some of my already smallish position (I was spooked by management sudden resignation so shortly after an unneeded offering).